Culture medium of hericium erinaceus, bio-converted mycelium, extract of the bio-converted mycelium, and application of the extract

A technology of biotransformation and Hericium erinaceus, applied to fertilizers made of biological waste, medical preparations containing active ingredients, applications, etc., can solve problems such as limited treatment methods and inability to treat thoroughly, and achieve good anti-tumor effects Effect
CN106064993AInactive Publication Date: 2016-11-02HUNAN XINHUI PHARMA
4 Cites 8 Cited by

Patent Information

Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
HUNAN XINHUI PHARMA
Publication Date
2016-11-02
Estimated Expiration
Not applicable · inactive patent

Smart Images

  • Figure 1
    Figure 1
  • Figure 2
    Figure 2
  • Figure 3
    Figure 3
Patent Text Reader

Abstract

The invention discloses a culture medium of hericium erinaceus, a bio-converted mycelium, an extract of the bio-converted mycelium, and an application of the extract. The culture medium is prepared by adding a traditional Chinese medicine, sculellaria barbata, to a base culture medium and includes the base culture medium and the sculellaria barbata. 100 parts of the culture medium includes 50-70 parts of the base culture medium and 30-50 parts of the sculellaria barbata, wherein the base culture medium includes, by weight, 350-490 parts of wheat bran, 100-140 parts of corn flour, 45-63 parts of grain bran, 5-7 parts of white sugar and 400-600 parts of water. The bio-converted mycelium is a product that is prepared by inoculating the hericium erinaceus on the culture medium through mycelium conversion. The extract of the bio-converted mycelium is prepared by water-extracting and then pressure-reduced-concentrating the hericium erinaceus mycelium and finally performing vacuum freeze-drying. The extract of the bio-converted mycelium has the effect of resisting gastrointestinal cancer, wherein the effect is significantly better than that of the hericium erinaceus mycelium and the sculellaria barbata independently, so that the extract can be used for preparing an anti-gastrointestinal cancer medicine.
Need to check novelty before this filing date? Find Prior Art

Description

technical field

[0001] The invention relates to the technical field of biopharmaceuticals, in particular to a culture medium of Hericium erinaceus, a biotransformation mycelium, an extract of the biotransformation mycelium and uses thereof. Background technique

[0002] Hericium erinaceus, a mushroom (fungi) of the family Hericium erinaceae, has been used in traditional Chinese medicine to treat gastrointestinal diseases for more than 2,000 years. A series of small molecule compounds, such as erinacines, are believed to have nerve regeneration and can pass through The blood-brain barrier repairs damaged nervous tissue. Hericium erinaceus also has anti-ulcer, anti-inflammatory, anti-microbial, immune regulation, improving liver function, anti-aging, lowering blood sugar and blood lipids, improving anti-hypoxia ability, increasing cardiac output, and improving circulation, etc., including Hericium erinaceus The medical preparations of are widely used in China.

[0003] The m...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More